Users of this system, can login to view this document.
Login
Enter the following information to request a copy of the document.For more information, please see: Copying Services.
ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2-specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report
This email address is used for sending the document.
